Company: MLTX
Filing Date: 2025-02-26
Form Type: 8-K
Source: 0001821586-25-000004
Chunk: 0

Company: MoonLake Immunotherapeutics
Filing Date: 2025-02-26
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02. Results of Operations and Financial Condition.

On February 26, 2025, MoonLake Immunotherapeutics (the “ Company”) issued a press release announcing its financial results for the quarter and fiscal year ended December 31, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

This Item 2.02 and the Press Release attached hereto as Exhibit 99.1, insofar as they disclose information regarding the Company’s results of operation and financial condition for the quarter and year ended December 31, 2024, are being furnished to the Securities and Exchange Commission.